Article Details

Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Receives Average Rating of "Buy" from Brokerages

Retrieved on: 2020-08-25 17:22:30

Tags for this article:

Click the tags to see associated articles and topics

Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Receives Average Rating of "Buy" from Brokerages. View article details on hiswai:

Excerpt

<div><b>AQR Capital Management</b> LLC now owns 44,808 shares of the company's stock worth $664,000 after acquiring an additional 34,079 shares during the ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo